Page last updated: 2024-12-11

biofor 389

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6439259
SCHEMBL ID8291651
MeSH IDM0195849

Synonyms (15)

Synonym
127245-22-1
mgj3xbs5kd ,
unii-mgj3xbs5kd
biofor-389
bf-389
biofor 389
2h-1,2-oxazin-3(4h)-one, dihydro-4-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)-2-methyl-
4-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2-methyl-5,6-dihydro-2h-1,2-oxazin-3(4h)-one
2h-1,2-oxazin-3(4h)-one, 4-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)dihydro-2-methyl-
bf 389
dihydro-4-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2-methyl-2h-1,2-oxazin-3(4h)-one
(4e)-4-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-2-methyloxazinan-3-one
SCHEMBL8291651
Q27284014
AKOS040747984

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Peak plasma concentrations occurred 2 to 4 hr postdosing and the half-life was 8 to 15 hr over the 1- to 250-mg/kg/day dose range."( Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389.
Bendele, AM; Benslay, DN; Lee, SJ; Lindstrom, TD; Naismith, RW; Ruterbories, KJ; Spaethe, SM, 1992
)
0.28

Dosage Studied

ExcerptRelevanceReference
" Carrageenan was injected into the footpad of each animal 1 hr after dosing and volumes of both hind paws were determined 3 hr later."( Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389.
Bendele, AM; Benslay, DN; Lee, SJ; Lindstrom, TD; Naismith, RW; Ruterbories, KJ; Spaethe, SM, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.40 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]